Cargando…
Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanism
TAZ, one of the key effectors in the Hippo pathway, is often dysregulated in breast cancer, leading to cancer stemness, survival, and metastasis. However, the mechanistic bases of these tumor outcomes are incompletely understood and even less is known about the potential role played by the non-malig...
Autores principales: | Shen, He, Zhang, Yuwen, Kramer, Elliot D., Katsuta, Eriko, Wan, Yin, Chen, Yanmin, Wang, Jianmin, Zhang, Yali, Matsuzaki, Junko, Frangou, Costa, Abrams, Scott I., Zhang, Jianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663307/ https://www.ncbi.nlm.nih.gov/pubmed/35840667 http://dx.doi.org/10.1038/s41417-022-00502-0 |
Ejemplares similares
-
The Hippo Signaling Transducer TAZ Regulates Mammary Gland Morphogenesis and Carcinogen-induced Mammary Tumorigenesis
por: Denson, Kayla E., et al.
Publicado: (2018) -
Genome-Wide Characterization of TAZ Binding Sites in Mammary Epithelial Cells
por: Liu, Tao, et al.
Publicado: (2023) -
The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
por: Hillmer, Ryan E., et al.
Publicado: (2019) -
Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach
por: Shen, He, et al.
Publicado: (2021) -
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
por: Benedetto, Anna Di, et al.
Publicado: (2016)